{"disease":{"id":"recurrent-glioblastoma-or-other-glioma-subtypes","name":"recurrent glioblastoma or other glioma subtypes"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01975701","title":"A Phase 2 Study of BGJ398 in Patients With Recurrent GBM","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}